View

The Study

Enhanced 2-arachidonoyl glycerol-dependent CB1 activation contributes to feeding dysregulation in KK-Ay mice.

In simple terms

This study looked at obese mice and found that when they ate more, certain chemicals in their guts were higher. When scientists blocked those chemicals, the mice ate less. But this doesn't mean the same thing happens in people—it's just one type of mouse in a lab.

8%

Analysis score

8/ 72

Maximum 72 for a cohort study.

Where the score came from

Reporting0
Methodology19
Publication100
Statistical0
Study type (basis of the score)
Cohort Study
Level 2b - Individual cohort study
What’s the bottom line?

Obese mice eat more often because their guts make too much of a chemical (2-AG) that tricks their brain into feeling hungry. Blocking this chemical or its receiver (CB1) makes them eat less.

Where does this study sit?

Reviews of RCTs (Meta-analyses)

Max 100

Randomized Trials

Max 90

Reviews of Cohort Studies

Max 85

Cohort Studies

Max 72

Reviews of Case-Control Studies

Max 63

Case-Control Studies

Max 58

Cross-Sectional & Case Series

Max 50

Expert Opinion

Max 5
StrongerWeaker
Cohort Studies
Level 2b
8

8 / 100

Quality score

Groups of people are followed over time to see who develops an outcome. Strong for identifying risk factors and associations, but cannot prove causation as firmly as RCTs.

Cannot establish causation

Save studies & get personalized insights

Create a free account to save this study, track new evidence as it comes in, and get breakdowns of studies in the topics you care about.

Key takeaways

Summary

Based on the study abstract and findings.

  1. 1Yes — this suggests that in obesity, gut chemicals may overstimulate hunger signals, leading to frequent eating even when not physically hungry.
  2. 2Obese mice had higher levels of 2-AG and prostaglandins in their guts.
  3. 3When scientists blocked 2-AG production or CB1 receptors, food intake dropped significantly.

Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data

Publication

Journal

The British journal of nutrition

Year

2026

Authors

Miki Igarashi, Kensuke Iwasa, Shinji Yamamoto, Takayo Ohto-Nakanishi, Ikuo Kimura, K. Yoshikawa

Open Access
Analysis v5

Related Content

Claims (6)

Assertion

Consuming linoleic acid, a type of fat found in certain oils, leads to the production of molecules that bind to CB1 receptors in the brain, which can lead to an increase in hunger.

Mechanistic
Read analysis
Assertion

In a specific strain of obese mice, overeating occurs because they eat more frequently, not because they eat larger meals or wait longer between meals. This suggests that the biological signals controlling hunger, not fullness, are altered.

Mechanistic
Read analysis
Assertion

Blocking the enzyme cyclooxygenase-2 decreases eating behavior in KK-Ay mice, suggesting that prostaglandins, along with endocannabinoids, play a role in driving excessive food intake in this genetically obese mouse strain.

Mechanistic
Read analysis
Assertion

In a specific strain of obese mice, higher levels of a fat-related molecule in the intestine correlate with more frequent eating, and blocking a specific receptor in the gut reduces food intake, suggesting this molecular pathway plays a role in overeating.

Mechanistic
Read analysis
Assertion

In mice with a genetic form of obesity, certain signaling molecules derived from arachidonic acid are found at higher concentrations in the intestines compared to lean mice, suggesting a change in how these fat-related compounds are processed in the gut.

Descriptive
Read analysis
Assertion

Blocking the enzyme that produces 2-arachidonoyl glycerol reduces eating behavior in KK-Ay mice, suggesting that this lipid molecule plays a required role in sustaining excessive food intake in this strain.

Mechanistic
Read analysis
Fit Body Science verdict — we translate health studies into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.